PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportslaron syndrome
MeSH D046150 - laron syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004392:Dwarfism
11 Companies
2 Drugs
$
Success rate
D046150: 
Laron syndrome
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
IpsenMecasermin Increlex  2007-08-02   
Clinical Trials
Historical Success Rate
Phase 1
100%
7/7
Phase 2
53%
8/15
Phase 3
28%
5/18
Approved: 2Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Ipsen
Mecasermin,
Mecasermin rinfabate,
Viaject
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use